Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Return on Equity (2022 - 2025)

CervoMed's Return on Equity history spans 8 years, with the latest figure at 0.86% for Q3 2025.

  • For Q3 2025, Return on Equity fell 71.0% year-over-year to 0.86%; the TTM value through Sep 2025 reached 0.86%, down 71.0%, while the annual FY2024 figure was 0.7%, 129.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.86% at CervoMed, down from 0.66% in the prior quarter.
  • Across five years, Return on Equity topped out at 58.63% in Q2 2022 and bottomed at 0.92% in Q4 2023.
  • The 4-year median for Return on Equity is 0.15% (2024), against an average of 3.81%.
  • The largest YoY upside for Return on Equity was 65bps in 2023 against a maximum downside of -5830bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 0.54% in 2022, then crashed by -272bps to 0.92% in 2023, then surged by 58bps to 0.38% in 2024, then tumbled by -124bps to 0.86% in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Return on Equity are 0.86% (Q3 2025), 0.66% (Q2 2025), and 0.51% (Q1 2025).